Ann: Kazia change in directors interests, page-25

that’s very incorrect:

anyone taking up the the last two CRs is effectively 275% up today! - .40 to 1.10 today!!!

we own two products Cantrixil and Paxalisib hence the negotiations with partners for lic deals and all our swag of partner trials at little or no cost to Kazia - starting to report news we all knew was coming and hence the radical re-rating of SP and with much more on the way.

thank god james came onboard and thank god he had the capability to drive and secure ownership of Paxalisib and thank god he is able to recognise the requirement for and has driven a restructure that delivers so much value driving us to a MC of 100+ million

still in the foot hills now but nice to see SPs at $1+ and heading toward $2 in the next couple of readouts.

———

if this is a lottery ticket then you should be so lucky as to acquire that ticket when entering a phase 3 pivotal study for FDA approval which even our conservative management predicts a 85% chance of approval!!!

in other-words - well well more likely than not at this late stage.

a potential 85% successful lottery ticket is a ticket you’d be mad not to own all you can of....

I don’t think ‘lottery’ is the right descriptor when a thing is more likely than not... particularly when you are referring to the new standard of care in GBM and DiPG (by definition of DiPG having no treatment at all).

lets flip that around and call it properly based on % as ...

“A sure thing, less maybe 15% a sure thing”

for GBM alone...

+ DiPG + brain Mets + more